ICD Code M60.19

ICD code M6019 is used to classify and document the diagnosis of interstitial myositis affecting multiple sites in the body. Interstitial myositis is a type of inflammatory muscle disease characterized by inflammation and degeneration of the muscle tissue, which can lead to muscle weakness and pain. The term "multiple sites" indicates that this condition is not localized to a single area but affects various muscles throughout the body. This code is essential for healthcare providers to accurately record and communicate the diagnosis for treatment planning, billing, and insurance purposes.

When considering the use of the ICD code M6019 for interstitial myositis at multiple sites, the following diagnostic criteria and symptoms should be evaluated:

1. Muscle Weakness
- Progressive weakness in proximal muscles, such as shoulders and hips.

2. Muscle Pain
- Complaints of myalgia or discomfort in affected muscle groups.

3. Fatigue
- Persistent fatigue that is disproportionate to activity levels.

4. Elevated Muscle Enzymes
- Increased levels of creatine kinase (CK) or other muscle enzymes in blood tests.

5. Muscle Biopsy Findings
- Histological evidence of inflammation in muscle tissue, typically showing infiltrates of lymphocytes.

6. Electromyography (EMG) Results
- Abnormal findings on EMG indicating myopathic changes or inflammation.

7. Skin Manifestations
- Presence of dermatomyositis-like rashes, if applicable, though not always present.

8. Systemic Symptoms
- Associated symptoms such as fever, weight loss, or arthralgia.

9. Exclusion of Other Conditions
- Ruling out other myopathies or systemic diseases that could explain the symptoms.

10. Multiple Sites Involvement
- Confirmation that the inflammatory process is affecting multiple muscle groups rather than localized areas.

These criteria should be carefully assessed to ensure accurate coding and appropriate management of the condition.

For the ICD code M60.19, which refers to interstitial myositis at multiple sites, the relevant CPT codes that may be applicable for treatment or management include:

1. CPT 20552 - Injection(s); single or multiple trigger point(s), 1 or 2 muscle(s).

2. CPT 20553 - Injection(s); single or multiple trigger point(s), 3 or more muscles.

3. CPT 97110 - Therapeutic exercises to develop strength and endurance, range of motion, and flexibility (each 15 minutes).

4. CPT 97112 - Neuromuscular reeducation of movement, balance, coordination, kinesthetic sense, posture, and/or proprioception for sitting and/or standing activities (each 15 minutes).

5. CPT 97140 - Manual therapy techniques (e.g., mobilization/manipulation, manual lymphatic drainage, manual traction), one or more regions, each 15 minutes.

6. CPT 99201-99215 - Evaluation and management services, depending on the complexity and time spent with the patient.

These CPT codes are commonly used in the treatment and management of conditions related to interstitial myositis and should be selected based on the specific services provided to the patient. Always ensure that the chosen CPT codes accurately reflect the services rendered and are supported by appropriate documentation.

Discover how MD Clarity's RevFind software can enhance your revenue cycle management by accurately reading your contracts and detecting underpayments for CPT codes associated with ICD code M6019. Schedule a demo today to see how RevFind can ensure you're receiving the full reimbursement you deserve.